Healthcare -
Biotechnology - NASDAQ - US
$ 0.0626
-5.15 %
$ 6.98 M
Market Cap
-0.09
P/E
EYEN - COST OF REVENUE
Cost of Revenue EYEN - Eyenovia, Inc.
3.79 K
LAST VALUE
-95.13%
2 YEAR CAGR
-27.67%
5 YEAR CAGR
0.00%
10 YEAR CAGR